Antiva Biosciences
Developer of small molecule antivirals designed to improve health outcomes for patients suffering from diseases caused by HPV and other viruses. The company's antivirals are based on a medicinal chemi...
Valuation
$123M
Latest known
Share Price
N/A
Total Raised
$144.8M
Last Round
N/A